Pulse Brain · Growing Health Evidence Index
Tier 2 — RCT, large cohort or strong causal designPeer-reviewed

Omega-3 Fatty Acid Supplementation Has Coronary and Other Selective Health Benefits: Comprehensive Results from the VITamin D and OmegA-3 TriaL (VITAL).

Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Luttmann-Gibson H, Albert CM, Mehrtash F, D'Agostino D, Ridge C, Bubes V, Walter JA, Danik JS, Buring JE, VITAL Research Group.

The Journal of nutrition · 2026

Read source ↗ All evidence

Summary

VITAL is a large-scale randomised controlled trial of marine omega-3 fatty acid supplementation (1 g/day) versus placebo in 25,871 US adults aged ≥50/≥55 years for primary cardiovascular and cancer prevention. Whilst supplementation did not reduce overall major cardiovascular disease events, it significantly reduced total myocardial infarction, fatal myocardial infarction, coronary revascularisation procedures, and heart failure hospitalisation, and was associated with reduced autoimmune disease risk. The intervention showed no effect on atrial fibrillation, cancer incidence, or all-cause mortality, with treatment effects modified by race, baseline fish intake, and cardiovascular risk profile.

Regional applicability

The study was conducted in the United States and may have limited direct applicability to UK populations, which typically have different dietary patterns, healthcare systems, and demographic profiles. However, the findings are relevant to UK evidence on omega-3 supplementation efficacy for cardiovascular disease prevention and could inform NHS guidance on fish oil supplementation, particularly regarding selective cardiac benefits in lower-risk general populations.

Key measures

Hazard ratios for major cardiovascular disease events, myocardial infarction (total and fatal), percutaneous coronary intervention, heart failure hospitalisation, atrial fibrillation, cancer incidence, autoimmune disease, all-cause mortality; effect modification by demographic, dietary and clinical factors

Outcomes reported

The study measured effects of 1 g/day marine omega-3 fatty acid supplementation on major cardiovascular disease events, myocardial infarction, heart failure, atrial fibrillation, cancer incidence, autoimmune disease, and all-cause mortality over a median 5.3-year follow-up period in 25,871 adults.

Theme
Nutrition & health
Subject
Dietary fats & fatty acids
Study type
Research
Study design
RCT
Source type
Peer-reviewed study
Status
Published
Geography
United States
System type
Human clinical
DOI
10.1016/j.tjnut.2026.101941
Catalogue ID
NRmwjc6lqv-000

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.